Pharmacist Discharge Medication Reconciliation Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-10-31

Study Completion Date

2008-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Adverse drug events can occur commonly due to medication errors during the transition of care in a health care facility. Medication reconciliation is the process of comparing medications and providing an accurate medication list as a resource for prescribers, which is currently only being done upon inpatient admission at the CCI. The purpose of this study is to see if pharmacist medication reconciliation at discharge reduces unintentional medication discrepancies for inpatient discharges.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effectiveness of Pre-Consultation Medication Reconciliation Service in Reducing Unintentional Medication Discrepancies During Transition of Care From Hospital Discharge to Primary Care Setting

NCT03181906

Medication Administered in Error Medication Adherence

COMPLETED NA

Using Novel Canadian Resources to Improve Medication Reconciliation at Discharge

NCT01179867

Medication Reconciliation Adverse Drug Events

COMPLETED NA

Eliminating Risk of Preventable Adverse Drug Events at the Hospital-community Interface of Care

NCT01164137

Adverse Drug Events

COMPLETED NA

Medication Reconciliation at Discharge: Impact on Patient's Care

NCT03029052

Medication Reconciliation

COMPLETED NA

Study to Assess the Impact of Medication Reconciliation at Hospital Admission on Healthcare Outcomes

NCT03654963

Safety Issues

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Medication Reconciliation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MRS

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Cancer inpatients under the care of Dr. Follett or Dr. Candler
* Cancer inpatients to be discharged from the CCI
* Patients \>18 years of age
* Patients that are taking \>1 medications or herbals total at home.

Exclusion Criteria

* Cancer inpatients that are considered radioactive or in "hot rooms" (ie. Selectron patients or patients receiving radiation treatment for thyroid)
* Patients that do not remain in hospital \>72 hours
* Patients without a home phone number or equivalent contact number.
* Language barrier (patients unable to speak or understand English).
* Patients that are readmitted and already included into the study.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No